Xiao Changchun, Srinivasan Lakshmi, Calado Dinis Pedro, Patterson Heide Christine, Zhang Baochun, Wang Jing, Henderson Joel M, Kutok Jeffrey L, Rajewsky Klaus
Immune Disease Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.
Nat Immunol. 2008 Apr;9(4):405-14. doi: 10.1038/ni1575. Epub 2008 Mar 9.
The genomic region encoding the miR-17-92 microRNA (miRNA) cluster is often amplified in lymphoma and other cancers, and cancer cells carrying this amplification have higher expression of miRNA in this cluster. Retroviral expression of miR-17-92 accelerates c-Myc-induced lymphoma development, but precisely how higher expression of miR-17-92 promotes lymphomagenesis remains unclear. Here we generated mice with higher expression of miR-17-92 in lymphocytes. These mice developed lymphoproliferative disease and autoimmunity and died prematurely. Lymphocytes from these mice showed more proliferation and less activation-induced cell death. The miR-17-92 miRNA suppressed expression of the tumor suppressor PTEN and the proapoptotic protein Bim. This mechanism probably contributed to the lymphoproliferative disease and autoimmunity of miR-17-92-transgenic mice and contributes to lymphoma development in patients with amplifications of the miR-17-92 coding region.
编码miR-17-92微小RNA(miRNA)簇的基因组区域在淋巴瘤和其他癌症中常发生扩增,携带这种扩增的癌细胞在该簇中的miRNA表达更高。miR-17-92的逆转录病毒表达加速了c-Myc诱导的淋巴瘤发展,但miR-17-92的高表达究竟如何促进淋巴瘤发生仍不清楚。在这里,我们构建了淋巴细胞中miR-17-92表达更高的小鼠。这些小鼠发生了淋巴细胞增殖性疾病和自身免疫,并过早死亡。来自这些小鼠的淋巴细胞显示出更多的增殖和更少的活化诱导细胞死亡。miR-17-92 miRNA抑制了肿瘤抑制因子PTEN和促凋亡蛋白Bim的表达。这种机制可能导致了miR-17-92转基因小鼠的淋巴细胞增殖性疾病和自身免疫,并促成了miR-17-92编码区域扩增患者的淋巴瘤发展。